Notably, while these metabolic parameters in MSC-treated DM mice remained statistically distinct from healthy controls, the observed attenuation of hyperglycemia and improved insulin sensitivity collectively demonstrate the therapeutic potential of MSC administration for modulating DM metabolic dysregulation. The gene discussed is INS; the disease is diabetes mellitus.